Related Experiment Video
Updated: Aug 19, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
[Pathogenetic approaches to the treatment of sleep disorders in comorbid patients]
1Pirogov Russian National Research Medical University, Moscow, Russia.
Insights
Insomnia exacerbates cardiovascular disease through inflammation and neurodegeneration. Peptide preparations like Cortexin show promise for treating sleep disorders and breaking this harmful cycle.
Area of Science:
- Neuroscience
- Cardiology
- Pharmacology
Context:
- Cardiovascular disease (CVD) incidence is rising, linked to sleep disorders like insomnia.
- Insomnia initiates a detrimental cycle involving inflammation, hypothalamic-pituitary-adrenal axis disruption, neurodegeneration, and cognitive decline.
Purpose:
- To explore the role of peptide preparations in managing sleep disorders and associated CVD risks.
- To evaluate Cortexin as a potential pathogenetic therapy for sleep disorders.
Summary:
- Peptide preparations offer a unique therapeutic approach by interacting with specific receptors to stimulate brain factors.
- Cortexin, a Russian peptide with extensive research, demonstrates potential for treating sleep disorders.
- Unlike other drugs, peptides can form new conformations with endogenous peptides, avoiding adverse effects and interactions.
Impact:
- This research highlights a novel therapeutic strategy for sleep disorders, potentially mitigating associated cardiovascular risks.
- Cortexin may offer a safe and effective treatment option for patients suffering from sleep disorders and related conditions.
Abstract:
The sharp increase in cardiovascular disease is associated not only with known risk factors, but also with a massive increase in sleep disorders. with insomnia, it triggers a pathogenic vicious circle: insomnia-inflammation-disturbance of the hypothalamic-pituitary-adrenal axis-neurodegeneration-cognitive dysfunction. Currently, a number of pharmacological modulators have been described that can activate the cell survival system. A special role is given to peptide preparations. They have a unique ability to create new conformations with the body's own peptides without causing adverse effects, without entering into antagonistic relationships with other drugs, without affecting systemic hemodynamics. Small peptides, which, while not actually neurotrophins, specifically interact with the corresponding receptors, stimulate the synthesis of releasing active factors in the corresponding regions of the brain. Cortexin, the first Russian peptide with the largest evidence-based experimental and clinical base, can be recommended as a means of pathogenetic therapy for sleep disorders.
More Related Videos
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
Related Concept Videos
Management of Insomnia
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Theoretical Approaches to Psychological Disorder
Biological approach
The biological approach posits that internal, organic factors are the primary causes of such disorders. This perspective emphasizes brain structure and function, genetic predispositions, and neurotransmitter imbalances. For example, schizophrenia has been associated with both genetic...
Narcolepsy